Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

Announcement on Voluntary Disclosure of Acceptance of the Marketing Authorization Application for the Class 2 Modified New Drug -Morphine Sulfate and Naltrexone Hydrochloride Sustained-release Capsules

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Acceptance of the Marketing Authorization Application for the Class 2 Modified New Drug -Morphine Sulfate and Naltrexone Hydrochloride Sustained-release Capsules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment